LIQUIDSEQ FOCUS GENOMIC PROFILING [65DNA+6RNA]- Includes MSI

Individuals diagnosed with solid tumors or advanced-stage cancers who may benefit from targeted therapy or personalized treatment planning. Cancer patients whose tissue biopsy is unavailable, insufficient, or difficult to obtain and require a non-invasive liquid biopsy approach. Patients undergoing cancer treatment who need molecular profiling, treatment selection, or monitoring of genetic changes during the course of therapy.